The orthopedic regenerative surgical products market is segmented by product, end-use, and application.
Product:
Allografts segment: The allografts segment is expected to dominate the orthopedic regenerative surgical products market due to the increasing prevalence of musculoskeletal disorders and the growing demand for minimally invasive procedures.
Viscosupplements segment: The viscosupplements segment is also anticipated to witness significant growth, driven by the rising geriatric population and the increasing adoption of non-surgical treatment options for osteoarthritis.
End-use:
Hospitals segment: The hospitals segment is projected to hold a substantial market share in the orthopedic regenerative surgical products market, attributed to the higher patient footfall in hospitals for orthopedic procedures and the presence of advanced surgical infrastructure.
ASCs segment: The ambulatory surgical centers (ASCs) segment is expected to register a steady growth rate, supported by factors such as shorter hospital stays, lower healthcare costs, and advancements in outpatient surgical techniques.
Application:
The application segment of the orthopedic regenerative surgical products market includes osteoarthritis, soft tissue repair, and spinal fusion, among others. Osteoarthritis is anticipated to be the leading application segment, driven by the rising prevalence of this degenerative joint disease and the increasing adoption of regenerative surgical products for its treatment. Soft tissue repair and spinal fusion applications are also expected to contribute significantly to the market growth, owing to the growing demand for innovative regenerative solutions for complex orthopedic conditions.